Evaluation of Application Value of mRNA Vaccines
DOI:
https://doi.org/10.54097/cwxh3m70Keywords:
mRNA vaccine; COVID-19; Pancreatic cancer; side effects; development.Abstract
With the prevalence of various diseases, there are many newly developed drugs and treatment methods. Vaccine is one of the widely used methods to prevent and treat some diseases including some infectious diseases and cancer. These days, there is a promising research field that has significant therapeutic benefits called messenger RNA vaccine (mRNA). mRNA vaccine has a prominent treatment efficacy which uses mRNA to trigger the immune response of the human body. Currently, the development of the mRNA vaccine has already reached many aspects, especially in treating COVID-19 and pancreatic cancer. At present, although mRNA vaccines have significant advantages over other vaccines, there are still some gaps in their side effects and development prospects. This review summarizes the current application of the mRNA vaccine and evaluates its efficacy and future development in order to have a comprehensive understanding of the current situation and a clear plan for future research and how to solve some tough issues.
Downloads
References
Iwasaki A, Omer SB. Why and How Vaccines Work. Cell. 2020, Oct 15;183(2):290-295.
Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Mol Ther. 2019, Apr 10;27(4):710-728.
Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology. Nat Rev Drug Discov. 2018, Apr;17(4):261-279.
Liu MA. A Comparison of Plasmid DNA and mRNA as Vaccine Technologies. Vaccines (Basel). 2019, Apr 24;7(2):37.
Al Fayez N, Nassar MS, Alshehri AA, Alnefaie MK, Almughem FA, Alshehri BY, Alawad AO, Tawfik EA. Recent Advancement in mRNA Vaccine Development and Applications. Pharmaceutics. 2023, Jul 18;15(7):1972.
Mirtaleb MS, Falak R, Heshmatnia J, et al. An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations. Int Immunopharmacol. 2023, Apr;117:109934.
Rosa SS, Prazeres DMF, Azevedo AM, Marques MPC. mRNA vaccines manufacturing: Challenges and bottlenecks. Vaccine. 2021, Apr 15;39(16):2190-2200.
Al Fayez, N.; Nassar, M.S.; Alshehri, A.A.; et al. Tawfik, E.A. Recent Advancement in mRNA Vaccine Development and Applications. Pharmaceutics. 2023, 15, 1972.
[9] Wilson B, Geetha KM. Lipid nanoparticles in the development of mRNA vaccines for COVID-19. J Drug Deliv Sci Technol. 2022, Aug;74:103553.
Benteyn D, Heirman C, Bonehill A, Thielemans K, Breckpot K. mRNA-based dendritic cell vaccines. Expert Rev Vaccines. 2015, Feb;14(2):161-76.
Fang E, Liu X, Li M, et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther. 2022, Mar 23;7(1):94.
Hu, B., Guo, H., Zhou, P. et al. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021,19, 141–154 ().
Miao L, Zhang Y, Huang L. mRNA vaccine for cancer immunotherapy. Mol Cancer. 2021, Feb 25;20(1):41.
Li Y, Wang M, Peng X, et al. mRNA vaccine in cancer therapy: Current advance and future outlook. Clin Transl Med. 2023 Aug;13(8): e1384.
Chehelgerdi, M., Chehelgerdi, M. The use of RNA-based treatments in the field of cancer immunotherapy. Mol Cancer. 2023, 22, 106.
Yasmin F, Najeeb H, Naeem U, et al. Adverse events following COVID-19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia. Immun Inflamm Dis. 2023, Mar;11(3): e807.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
